Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Aug 28;19(8):e0300911. doi: 10.1371/journal.pone.0300911

Estimation equation of limb lean soft tissue mass in Asian athletes using bioelectrical impedance analysis

Yeong-Kang Lai 1, Chu-Ying Ho 1, Ai-Chun Huang 2, Hsueh-Kuan Lu 3, Kuen-Chang Hsieh 4,5,*
Editor: Gianpiero Greco6
PMCID: PMC11356429  PMID: 39196957

Abstract

Background

The lean soft tissue mass (LSTM) of the limbs is approximately 63% of total skeletal muscle mass. For athletes, measurement of limb LSTM is the basis for rapid estimation of skeletal muscle mass. This study aimed to establish the estimation equation of LSTM in Asian athletes using bioelectrical impedance analysis (BIA).

Methods

A total of 198 athletes (121 males, 77 females; mean age 22.04 ± 5.57 years) from different sports in Taiwan were enrolled. A modeling group (MG) of 2/3 (n = 132) of subjects and a validation group (VG) of 1/3 (n = 68) were randomly assigned. Using the InBody S-10, resistance and reactance were measured at 50 kHz from the right palm to the right sole while the participant was in the supine position. Predictor variables were height (h), weight (W), age, Sex, Xc, resistance index (RI; RI = h2 / R). LSTM of arms and legs measured by dual-energy X-ray absorptiometry (DXA) was the response variable. Multivariate stepwise regression analysis method was used to establish BIA estimation equations as ArmsLSTMBIA-Asian and LegsLSTMBIA-Asian. Estimation equations performance was confirmed by cross-validation.

Results

Estimation equation "ArmsLSTMBIA-Asian = 0.096 h2/R– 1.132 Sex + 0.030 Weight + 0.022 Xc– 0.022 h + 0.905, r2 = 0.855, SEE = 0.757 kg, n = 132" and "LegsLSTMBIA Asian = 0.197h2/R" + 0.120 h– 1.242 Sex + 0.055 Weight– 0.052 Age + 0.033 Xc –16.136, r2 = 0.916, SEE = 1.431 kg, n = 132" were obtained from MG. Using DXA measurement results of VG for correlation analysis and Limit of Agreement (LOA) of Bland-Altman Plot, ArmsLST is 0.924, -1.53 to 1.43 kg, and LegsLST is 0.957, -2.68 to 2.90 kg.

Conclusion

The established single-frequency BIA hand-to-foot (whole body) estimation equation quickly and accurately estimates LSTM of the arms and legs of Asian athletes.

Introduction

In the field of sports science, research on the body composition of athletes has developed vigorously in recent years. Many studies have classified athletes by different phenotypes, including shape, weight, body fat percentage, fat mass, fat-free mass (FFM), lean soft tissue mass (LSTM), muscle mass (MM) and other body components. Due to different sports categories, sex, and competitive levels, early research focused on body fat percentage [1]. Current related research has been extended to total and regional skeletal muscle mass in athletes. More recently, these measurements, especially LSTM, are related to improving athletic performance and reducing the risk of injury [2]. However, assessments of body composition in individual athletes still need to be targeted as factors for problem-solving among athletes. In this way, individual athletes can obtain corresponding personal benefits when measuring body composition [3]. This innovative approach goes beyond previous fundamental issues of body composition and emphasizes movement-specific performance. For example, the characteristics of the body composition of arms, legs and torso are directly related to training progress [4].

The latest development of body composition technology divides the body into three-components, namely LSTM, FM and bone mineral content (BMC). LSTM includes whole body water, protein, carbohydrates, non-fat lipids, and soft tissue minerals [5]. The three-component body composition model can be used with dual-energy X-ray absorptiometry (DXA), magnetic resonance imaging (MRI), and computerized tomography (CT). Although CT and MRI provide information on muscle cross-sectional areas (CSA) and muscle volume (MV), these methods are costly, require relatively in-depth research expertise, and analysis of the results can be difficult. Therefore, these methods are not practical in the sports performance setting. Compared with the above methods, although the cost of DXA is lower, it still has limitations in application fields. Another measurement method used commonly in the two component model is bioelectrical impedance analysis (BIA). Because BIA is convenient, safe, non-invasive, and fast, it provides athletes with instant information on body composition measurements, and LSTM changes can be tracked conveniently during athlete training.

In women’s softball [6], men’s hockey [7] and soccer [8], the variability of the whole body and limb segment was the least. Among male college basketball players, centers players reflect that their arms and legs have the highest LSTM and FM compared to players in all other positions (with the exception of power forwards) [9]. American football players also have the same body composition as men’s basketball, with significant differences between the different positions [10, 11]. Results of these studies suggest that there may be a relationship between limb segments, body composition and exercise programs, positions, and specific functional needs (e.g., shooting, competitive season of hockey (and likely in football and other sports), the LSTM of the legs of excellent players will increase significantly as the season time increases [12]. For football players, the LSTMs on the legs and torso are also noted to increase significantly as the season progresses [13]. These studies have shown that body composition changes over time.

Since 1990, several important studies have been published on the use of BIA for estimates body composition in athletes [14, 15]. The measurement, comparison and validation studies of commercial BIA devices in LSTM or FFM for the whole body and limbs of athletes have been proposed and have gradually captured increasing attention [1618]. The physical characteristics of athletes are different from those of the general population based on long-term trends in specific sports [19]. Therefore, special mechanisms must be applied or dedicated regression equations to accurately measure body composition [20]. Recently, body composition estimation equations have been proposed to measure the body composition of athletes using BIA to distinguish Sex differences [21, 22]. A recent study by Sardinha et al. [23] proposed a BIA estimation equation for athletes using LSTM for upper and lower limbs, although the subjects of this study were Europeans and Americans. Published research has already shown ethnicity differences in the estimation of body composition by BIA [24]. In the past, there were some research on the measurement equation of FFM in athletes [14, 22, 25, 26], and recently there was research on the establishment of equations of LSTM in Caucasian athletes [23]. For athletes in the Asian region, the relevant research was very limited [27]. More cross-ethnic population studies on body composition are warranted. These studies should be meticulously conducted, employing suitable methodologies and standardization, to ensure the value of the gathered information [28]. Whether applicable or not, it is still necessary to further explore or establish a suitable LSTM estimation equation. Therefore, this study aimed to establish and verify the estimation equation of limb lean soft tissue mass by using BIA in Asian athletes. A single-frequency BIA hand-to-foot (whole body) estimation equation was established to quickly and accurately estimates the lean soft tissue mass of the arms and legs of Asian athletes.

Material and methods

Study design and sample

The subjects of this prospective observational study were all active high-level athletes in Taiwan and recruited between June 1, 2021 and March 30, 2022. Eligible participants engaged in at least 12 hours of physical or specialty training activities per week. Professional training time was 9.6 ± 2.5 years and received high-intensity or professional training for 12.3 ± 4.5 hours per week. They were all active players at the highest level in Taiwan and in the Asian or Olympic Games (except for dance specialties). Subjects did not drink alcoholic beverages 48 hours before the test, did not use diuretics for 7 days before the test, and did not participate in intense training 24 hours before the test. Females with menstrual periods were excluded [29]. All subjects had no history of nutritional, endocrine or growth disorders and had no more than 5 kg body weight change before the six experiments (Fig 1).

Fig 1. Flow chart of participants for the inclusion in the analysis for the study.

Fig 1

Ethical considerations

This study was conducted in the Department of Radiology, Dali Jen-Ai Hospital, Taichung City. Before the six experiments, the research protocol and experimental procedure were approved by the Human Experiment Committee of Taso-Tun Psychiatric Center, Ministry of Health and Welfare (IRB-11001). Before the tests began, the research assistant explained the experimental precautions to the subjects. Once the subjects understood the experimental process and their rights, they agreed to participate in the experiment and each subject provided signed informed consent. Informed consent was obtained from each participant and/or guardian if under the age of legal consent prior to testing. We conducted experiments in accordance with relevant guidelines and regulations.

Procedure and anthropometry

Three days before the experiment, the subjects were informed of the precautions. The subjects reported to the experimental site at 1:00 p.m. on the day of the experiment, and there is no lunch to maintain a fasting state before measurement. Filled out the questionnaire on basic personal information and training process, and changed into cotton robes for testing. The bladder of each subject was emptied 20 minutes before the experiment. Subjects were measured using Tanita BC-418MA (Tanita Co., Tokyo, Japan) with an accuracy of 0.1 kg. A height ruler (Holtain, Crosswell, Wales, UK) was used to measure the subjects’ height without shoes, providing accuracy of 0.5 cm. Body mass index (BMI) was calculated by dividing the subjects’ individual body weight by the square of the height in kg/m2. A cloth tape measure was used to measure subjects’ waist and hip circumferences. When measuring waist circumference, subjects placed feet together, relaxed the abdominal muscles, placed arms naturally at each side of the body, breathed normally, and allowed measurement of the narrowest position of the body below the ribs and above the navel. Hips were measured at the widest point. Waist and hip circumferences were measured twice, and the average values were recorded.

Impedance measurement

Resistance and reactance were measured from the dorsum of the right palm to the dorsum of the right foot using a bioimpedance analyzer, the S-10 (InBody Co., Ltd., Seoul, South Korea), operating at a frequency of 50 kHz while the participant was in a supine position. The positioning of the electrodes and body posture followed the instructions provided by the electrode manufacturer (BIATRODES® Akern Srl; Florence, Italy). The InBody S-10 is a Class II medical device approved by the FDA (Regulation Number: 870.2770). Resistors supplied by the manufacturer were used for calibration every day before the experiment. Bioimpedance measurement is done after confirming that accuracy of the bioimpedance measuring instrument meets the requirements. The subject lies on his/her back on a hospital bed. The right wrist and the back of the right foot were connected with silver electrode patches, which were the pair of receiving and transmitting electrodes, respectively. Subjects lay on their backs calmly for five minutes before the measurement was taken. The resistance index (RI) was defined as the ratio of the square of the height to the measured resistance at a frequency of 50 KHz (h2/R). For 5 male and 5 female subjects, impedance measurements were repeated 10 times within one hour of the day. Impedance measurements were performed by 5 subjects for each of the same male and female subjects in the same period for 4 consecutive days. The coefficient of variation (CV = standard deviation/mean × 100%) of impedance, resistance, reactance, and phase angle measurements was evaluated for within-day and between-day results, respectively. CVs were 0.2%-0.7%, 0.1%-0.8, 0.3–1.2%, 0.3–1.4% and 0.8%-1.6%, 0.9%-2.1%, 0.8%-1.7%, 1.0%-2.2% respectively.

Dual energy X-ray absorptiometry

Body composition was measured by DXA (Lunar Prodigy; GE Medical Systems, Madison, WI, USA) and the Microsoft software, Encore 2003 Version 7.0. The subjects performed the DXA measurement within thirty minutes immediately after the impedance measurement was completed. Each subject wore a light cotton robe and lay on the measuring bed in a relaxed supine position. The upper limbs were stretched and placed on both sides of the body, with toes facing upward and feet slightly side by side. The procedure took about 20 minutes for each test subject. Complete DXA measurement of body composition included LSTM, FM (fat mass), BMC (bone mineral content) on the whole body, left and right upper limbs, left and right lower limbs, trunk and other parts. The regions of interest (ROI) for the whole body, trunk, legs, arms, android, and gynoid were automatically determined by the software.

Statistical analysis

All data were expressed as means ± SDs, and range. Data were tested for normal distribution using the Kolmogorov-Smirnov test. All statistical analyses were performed using SPSS Ver.20 (Statistical Package for the Social Sciences, IBM SPSS statistics for Windows; IBM Corp., Armonk, NY, USA). The significance level was set at p < 0.05 (two-tailed). Given that a sample size of 124 participants was calculated considering a type 1 error of 5% and a power of 80% to achieve a moderate effect size for the R2 increases in the prediction equation with the inclusion of five predictors, our sample size of 198 athletes was sufficient for assuring an adequate power analysis in model development.

Paired-t tests were used to compare DXA and BIA on ArmsLSTM and LegsLSTM. The correlation between BIA estimates and DXA-measured ArmsLSTM and LegsLSTM was performed using Pearson’s correction and Lin’s concordance correlation coefficient (CCC). Bland-Altman plots were used to represent the mean difference and limit of agreement (LOA). The regression line was used to represent the trend.

Two-thirds (n = 132) and one-third (n = 66) of the total subjects were randomly divided into a modeling group (MG) and a validation group (VG), respectively. Height, weight, age, Sex, resistance index, and reactance were used as predictor variables, and the LSTM of upper limbs (arms) and lower limbs (legs) measured by DXA were used as response variables, which were expressed as ArmsLSTMDXA and LegsLSTMDXA, respectively. Stepwise regression analysis was performed with MG. Set parameters—forward (Fin = 4.00), backward (Fout = 3.99) to obtain the selected predictor variable. The resulting equations were ArmsLSTMBIA-Asian, LegsLSTMBIA-Asian and their corresponding regression coefficients, standard estimate error (SEE), coefficient of determination (r2), and predictor variables removed with VIF (variance inflation factor) > 4. The ArmsLSTMBIA-Asian and LegsLSTMBIA-Asian obtained by the VG data were brought into the MG, and were analyzed by correlation and Bland-Altman Plots, respectively, to evaluate the effectiveness of the LSTM estimation equation. Intraclass correlation coefficient (ICC) analysis was conducted using two repeated measurements to assess the reproducibility of estimating ArmLSTM and LegLSTM in this study. The measurement unit was kilograms (kg).

Results

A total of 198 male and female athletes participated in this study, including 121 male athletes (basketball: 11, swimming: 18, powerlifting: 8, judo: 10, long-distance running: 4, football: 26, wrestling: 37, track and field: 7), and 77 female athletes (basketball: 7, dance: 10, judo: 15, long-distance running: 2, tug-of-war: 9, soccer: 17, wrestling: 2, track and field: 15). The age, height, weight and body fat percentage of male athletes were 22.67 ± 5.82 years, 174.87 ± 8.25 cm, 74.9 ± 11.87 kg and 15.26 ± 6.83%, respectively. Fig 1 shows the flow chart of participants included in the study analysis. For female athletes, mean age, height, weight, and body fat percentage were 21.02 ± 5.00 years, 161.64 ± 6.86 cm, 58.15 ± 9.35 kg and 27.15 ± 8.06%, respectively. For all subjects, MG and VG personal characteristics parameters and body composition data are shown in Table 1.

Table 1. Physical characteristics of the subjects 1.

All Subject Male (n = 121) Female (n = 77) Total (n = 198)
Age(year) 22.7±5.8(17.0, 46.0) 21.0±5.0(17.0, 45.0) 22.0±5.6(17.0, 46.2)
Height(cm) 174.9±8.3(155.9, 198.3) 161.6±6.9(147.1, 181.9)3 169.7±10.1 (147.1, 198.3)
Weight(kg) 74.9±11.9(48.9, 123.9) 58.2±9.4(40.8,84.7)3 68.4±13.7 (40.8, 123.9)
BMI(kg/m2) 24.5±3.0(18.9, 36.0) 22.2±2.5 (17.7, 29.8)2 23.6±3.1(17.7, 36.0)
R(ohm) 483.4±52.2(339.8, 696.9) 602.5±54.7(452.0, 727.0)3 529.7±83.1(339.8, 724.0)
Xc(ohm) 64.7±8.9(43.4, 92.9) 70.9±7.4(55.8, 86.7)3 67.2±8.9(43.4, 92.9)
ArmsLSTM(kg) 7.0±1.4(2.7, 11.1) 3.8±0.8 (2.6,7.5)3 5.7±2.0(2.6, 11.1)
LegsLSTM(kg) 22.6±3.4(12.9, 33.7) 15.0±2.7(10.9,27.5)3 19.6±4.9(10.9,33.7)
TrunkLSTM(kg) 26.4±3.6(14.5–41.7) 17.8±2.1(13.8,27.1)3 22.8±5.3(13.8, 41.7)
FM% 15.3±6.8(5.10–34.0) 27.2±8.1(9.40,46.5)3 20.2±9.4(5.1, 46.5)
WHR 0.82±0.05(0.72,0.96) 0.80±0.06(0.65,0.94)3 0.81±0.05(0.65,0.96).
Modeling Group Male (n = 70) Female (n = 52) Total (n = 132)
Age(year) 22.9±6.1(17.0, 46.0) 20.9±5.0(17.0, 42.0)2 22.1±5.8(17.0, 46.0)
Height(cm) 174.8±7.8(157.3, 198.3) 160.9±6.4(150.3, 181.9)3 169.3±10.0(150.5, 198.3)
Weight(kg) 73.7±9.9(56.9,123.1) 57.4±8.7(40.8, 84.7)3 67.3±12.4(40.8, 123.1)
BMI(kg/m2) 24.1±2.7(18.9, 36.0) 22.1±2.5(17.7, 29.8)2 23.3±2.9(17.7, 36.0)
R(ohm) 483.8±58.8(339.8,679.5) 602.3±49.8(506.2, 704.7)3 530.5±80.2(339.8, 704.7)
Xc(ohm) 65.2±8.8(43.4, 89.9) 70.7±7.5(55.8, 86.8)3 67.3±8.7(43.4, 89.9)
ArmsLSTM(kg) 6.9±1.3(2.6, 9.4) 3.8±0.7(2.6, 6,8)3 5.7±1.9(2.6, 9.4)
LegsLSTM(kg) 22.5±3.0(15.4, 32.6) 14.8±2.4(10.9, 25.7)3 19.4±4.7(10.9, 32.6)
TrunkLSTM(kg) 26.3±3.6(14.5,41.7) 17.7±2.1(13.9,27.1)3 22.7±5.2(13.9,41.7)
BF% 15.2±7.1(5.4,33.7) 27.5±8.5(9.4,46.5)3 20.4±9.8(5.4,46.5)
WHR 0.81±0.05(0.72,0.96) 0.79±0.06(0.69,0.92)3 0.81±0.05(0.69,0.96)
Validation Group Male (n = 41) Female (n = 25) Total (n = 66)
Age(year) 22.1±5.3(18.0, 46.0) 21.3±5.2(17.0, 45.0)2 21.8±5.2(17.0, 46.0)
Height(cm) 175.0±9.1 (155.8, 194.6) 163.3±7.6(147.1, 178.1)3 170.6±10.3(147.1, 194.6)
Weight(kg) 77.4±18.8 (48.9, 119.1) 59.7±10.6(45.2, 81.2)3 70.7±15.9(45.2, 119.1)
BMI(kg/m2) 25.2±3.6(19.6, 33.7) 22.3±2.6(18.5, 29.4)2 24.1±3.5(18.5, 33.7)
R(ohm) 482.6±69.2(355.2, 696.9) 602.8±64.8(452.0, 724.0)3 528.1±89.2(355.2, 724.0)
Xc(ohm) 63.8±9.3(43.4, 92.8) 71.4±7.1(56.8, 83.7)3 66.7±9.2(43.4, 92.8)
ArmsLSTM(kg) 7.1±1.6(3.0, 11.1) 3.9±1.1(2.6, 7.5)3 5.9±2.1(2.6, 11.1)
LegsLSTM(kg) 22.7±4.2 (12.9, 33.7) 15.5±3.4(11.9, 27.5)3 20.0±5.3(11.9, 33.7)
TrunkLSTM(kg) 26.6±3.8(19.7,36.8) 17.8±1.9(13.8,23.0)3 22.9±5.4(13.8,36.8)
FM% 15.3±6.4(5.10,34.0) 26.4±7.1(13.5,40.7)3 20.0±8.6(5.1, 40.7)
WHR 0.82±0.04(0.74,0.84) 0.80±0.06(0.65,0.94)3 0.81±0.05(0.65,0.94)

1 All values are x ± SD; minimum and maximum in parentheses.

2,3 Significantly different from male (one-factor ANOVA): 2 P = 0.005, 3 P < 0.001; BMI, body mass index; R, resistance; Xc, reactance, LSTM, Lean soft tissue mass, WHR, Waist-to-hip ratio; FM%, Fat Mass % (body fat percentage).

In the present study, all subjects’ data were entered into the arms LSTM equation of Sardinha et al. [23] and compared with the present DXA measurement results. The scatter plots and regression line are shown in Fig 2a. The LOA and trend line of the two Bland-Altman Plots are shown in Fig 2b. The same procedure and data were entered into the lower limb LSTM equation and compared with the present DXA measurement results. The distribution plots and regression line are shown in Fig 2c. The LOA and trend line of the two Bland-Altman Plots are shown in Fig 2d. Fig 2a and 2c are scatter plots of ArmLSTM and LegLSTM estimates compared to DXA results using the Sardinha equation. The regression line (thin solid line) shows a weak fit with the equivalence line (dashed line), indicating that the accuracy of the Sardinha equation for estimating ArmLSTM and LegLSTM in Asian athletes is limited. The Bland-Altman plots in Fig 2b and 2d show the limits of agreement (LOA) for ArmLSTM and LegLSTM estimates using the Sardinha equation in Asian athletes. The trend line (dashed line) in the plots indicates a significant proportional bias between the two measurement methods.

Fig 2. Asian athletes were compared with DXA using the Sardinha equation.

Fig 2

(a) Scatter plots and regression line of ArmsLSTM (y = 1.358 x– 1.650, r = 0.812, p < 0.001, CCC = 0.784); (b) Bland-Altman Plots of ArmsLSTM (trend, y = −0.551 x + 2.780, p < 0.001); (c) Distribution plot and regression line of LegsLSTM (y = 1.359 x -3.941, r = 0.863, p < 0.001, CCC = 0.824); (d) Bland-Altman Plots of LegsLSTM (trend, y = −0.418 x + 6.714, p < 0.001).

The estimated variables selected in the stepwise regression analysis method, along with the corresponding regression coefficients, intercept, SEE, determination coefficient, variance inflation factor, and standardized coefficient of the estimation equation, are shown in Tables 2 and 3. In the stepwise regression analysis method, ArmLSTM was used as the response variable. Sequentially selected variables entered into the measurement equation using multivariate regression analysis were resistance index (h2/R), Sex (female = 0, male = 1), W (weight), Xc (resistance), and h (height). The increase in predictor variables and the corresponding coefficient of determination, standard error of the estimate (SEE), standardized coefficient (β), and variance inflation factor (VIF) are shown in Table 2. The best estimation equation for ArmsLSTM is as follows:

ArmsLSTMBIA-Asian=0.096h2/R1.132Sex+0.030W+0.022Xc0.022h+0.905,(r2=0.855,SEE=0.757kg,n=132,p<0.01) (1)

where: h2/R, resistance index; W, weight; Xc, reactance; h, height;

Table 2. Multiple regression analysis results for ArmsLSTM, based on bioimpedance index and anthropometric.

ArmsLSTM, Modeling Group (n = 132)
h2/R + Sex +Weight +Xc +h Intercept SEE r2 VIF β
-0.131 ± 0.005** - - - - -0.663 ± 0.270 ** 0.878 0.802 2.27 0.659
0.100 ± 0.006** -1.147 ± 0.171** - - - -0.547 ± 0.418 0.797 0.837 2.39 -0.281
0.094 ± 0.426** -1.184 ± 0.171** 0.026 ± 0.007** - - 0.094 ± 0.426* 0.775 0.847 3.57 0.211
0.087 ± 0.010** -1.102 ± 0.172** 0.025 ± 0.007** 0.019 ± 0.008** - -1.742 ± 0.871 0.765 0.848 1.66 0.098
0.096 ± 0011** -1.132 ± 0.171** 0.030 ± 0.007** 0.022 ± 0.008** -0.022 ± 0.010** 0.905 ± 1.462* 0.757 0.855 3.29 -0.112

ArmsLSTM, Arms lean soft tissue mass; Regression coefficient estimate ± SEE; r2, coefficient of determination;

* p < 0.01;

** p < 0.001;

β, standardized coefficient; VIF: variance inflation factor; SEE, standard error of the estimate; h, height.

Table 3. Multiple regression analysis results for LegsLSTM, based on bioimpedance index and anthropometric.

LegsLSTM, Modeling Group (n = 132)
h2/R +h + Sex +Weight +Age +Xc Intercept SEE r2 VIF β
.336±.010** - - - - .675±.554 1.792 .863 2.89 .546
.241±.014** .156±.019** - - - -20.496±2.577** 1.543 .899 3.35 .248
.213±.016** .150±.018** -1.151±.332** - - -17.497±2.653** 1.502 .905 2.42 -.125
.179±.018** .132±.019** -1.254±.325** .050±.014** - -15.845±2.263** 1.467 .911 3.60 .155
.178±.018** .127±.018** -1.362±.323** .053±.014** -.048±.019** -14.030±2.683 1.443 .914 1.04 -.059
.197±.020** .120±.019** -1.242±.324** .055±.014** -.052±.019** .033±.015* -16.139±2.826 1.431 .916 1.67 .060

LegsLSTM,Legs lean soft tissue mass; Regression coefficient estimate ± SEE; r2, coefficient of determination;

* p < 0.01;

** p < 0.001;

β, standardized coefficient; VIF: variance inflation factor; SEE, standard error of the estimate; h, height

Using the same measurement variables as for MG, LegsLSTM was the response variable, and applying multivariate stepwise regression analysis, the sequentially selected variables entered the measurement equation were h2/R, h, Sex, W, Age, and Xc. The corresponding coefficients of determination, SEE, VIF, and β are shown in Table 3. The optimal estimation equation of LegsLSTM is as follows:

LegsLSTMBIA-Asian=0.197h2/R+0.120h1.242Sex+0.055W0.052Age+0.033Xc16.136,r2=0.916,SEE=1.431kg,n=132;p<0.001 (2)

where: h2/R, resistance index; W, weight; Xc, reactance; h, height; Age, age; h, height; Sex (female = 0, male = 1);

Tables 2 and 3 have shown the choosing estimation variables and their orders when evaluating ArmsLSTM and LegsLSTM. VG data are entered into the formula (1) to obtain ArmsLSTMBIA-Asian, and compared with the ArmsLSTMDXA. The scatter diagram of ArmsLSTMBIA-Asian, ArmsLSTMDXA, regression line, Bland-Altman Plots and LOA calculation, were drawn, respectively, as Fig 3a and 3b. VG data entered into equation (2) to obtain LegsLSTMBIA-Asian, and its scatter and Bland-Altman Plots are shown in Fig 3c and 3d, respectively. Fig 3a and 3c show scatter plots of ArmLSTM and LegLSTM estimates compared to DXA results for the validation group. The regression line (thin solid line) closely aligns with the equivalence line (dashed line). The Bland-Altman plots in Fig 3b and 3d represent the ArmLSTM and LegLSTM estimation equations established by the model group. This indicates no proportional error in the validation group’s estimated results. The limits of agreement (LOA) in Fig 3b and 3d are significantly narrower than those in Fig 2b and 2d.

Fig 3. A new equation was developed to measure the outcomes of Asian athletes compared with DXA in the validation group (VG).

Fig 3

a. scatter plots and regression line of ArmsLSTM (y = 0.024 + 1.007 x, r = 0.924, p < 0.001, CCC = 0.913); b. Bland-Altman Plots of ArmsLSTM (Trend: y = 0.441–0.088 x, p > 0.05); c. Scatter plots and regression line of LegsLSTM (y = -0.094 + 1.000 x, r = 0.957, p < 0.001, CCC = 0.943); d. Bland-Altman Plots of LegsLSTM (trend: y = 0.978–0.04 x, p > 0.05).

For males, females, and overall subjects, the resistance, reactance, and anthropometric parameters corresponded to the equations by Sardinha et al. [23]. The data of ArmsLSTMBIA-Asian, LegsLSTMBIA-Asian and DXA in this study are shown in Table 4.

Table 4. LegsLSTM and ArmsLSTM estimation equation by DXA and bioimpedance for Asian Athlete1.

Method Male (n = 121) Female (n = 77) Total (n = 198)
ArmsLSTM
DXA(kg) 6.99 ± 1.38 (2.69, 11.06) 3.79 ± 0.82 (2.6,7.5) ** 5.74 ± 1.97 (2.6, 11.1)
Sardinha [14] (kg) 5.93 ± 1.13 (3.03,9.75) 4.67 ± 0.76 (3.52, 7.37)** 5.44 ± 1.18 (3.14,7.,79)
Asian(kg) 6.92 ± 1.06 (4.25, 10.30) 3.74 ± 0.65 (2.72, 6.14) 5.74 ± 1.81 (2.14,9.92)
LegsLSTM
DXA (kg) 22.55 ± 3.42 (12.86, 33.70) 15.03 ± 2.74 (10.9,27.5) ** 19.62 ± 4.85 (10.9,33.7)
Sardinha [14] (kg) 18.58 ± 2.91 (11.09,29.11) 15.11 ± 2.30(11.24,22.97)** 17.33 ± 3.06 (11.34,23.45)
Asian (kg) 22.62 ± 3.14 (14.12,31.72) 15.03 ± 2.74 (10.98, 27.49) ** 19.62 ± 4.64 (10.61,28.98)

1 All values are x ± SD; minimum and maximum in parentheses. Significantly different from male (one-factor ANOVA):

*, P = .05,

**, P < .01

Shown in the Table 5, the correlation between ArmsLSTM and estimated variables was h2/R (r = 0.895), Weight (r = 0.794), Height (r = 0.725), R (r = -0.836), Sex (r = -0.795) according to the level of correlation. LegsLSTM was h2/ R (r = 0.929), height (r = 0.864), Weight (r = 0.839), R (r = -0.777), and Sex (r = -0.757). The estimates of error of ArmsLSTM and LegsLSTM were 0.171 and 0.582 kg. Reproducibility was 0.98, 0.99 respectively.

Table 5. Correlation coefficient matrix of independent and dependent variables (n = 198).

ArmsLSTM LegsLSTM Sex Wegith Xc R h 2 /R Age Height
ArmsLSTM 1 .908** -.795** .794** -.451** -.836** .895** .122 .725**
LegsLSTM 1 -.757** .839** -.487** -.777** .929** .034 .864**
Gender 1 -.601** .341** .701** -.748** -.145* -.642**
Weight 1 -.500** -.687** .833** .106 .765**
Xc 1 .624** -.597** .017 -.399**
R 1 -.900** -.133 -.517**
h 2 /R 1 .093 .811**
Age 1 .028
Height 1

where: h2/R, resistance index; Xc, reactance; R, resistance; h, height;

* p < 0.05;

** p < 0.001

Discussion

The present study established BIA estimation equations of LSTM for arms and legs for Asian athletes in Taiwan. Accordingly, this study is the first to compare the differences and applicability of BIA to LSTM estimation equations for Asian and European athletes. Cross-validation results showed that the BIA estimation equation established for athletes’ LSTM in this study has good performance and can be applied practically to the limb LSTM measurement of Asian athletes.

Through the measurement of limb LSTM, measuring whole-body skeletal muscle mass can be estimated indirectly, overcoming the difficulty associated with other whole-body measurement methods. Accurately measuring the LSTM of the limbs is exceptionally important for measuring the whole-body skeletal muscle mass of athletes [30]. This study used data measured from Asian athletes and applied the equation of Sardinha et al. For the upper limbs, the LSTM of female athletes was generally overestimated, while the LSTM of male athletes was slightly underestimated. For the lower limbs, the LSTM of male athletes was significantly underestimated. These results showed clear proportional effects, with greater underestimation as the LSTM of the upper and lower limbs increased. Therefore, the applicability of the LSTM estimation equation established for European athletes to Asian athletes must be carefully evaluated. Therefore, some scholars have conducted validation studies on the LSTM or FFM measurements of athletes’ limbs for commercial BIA devices. Brewer et al. [16] used DXA as a standard for comparison among male athletes at Division I College in the United States. The results showed that the LOA of Inbody770 measured by FFM (free fat mas, FFM) of the arms and legs of male athletes was −3.1 to 0.5 kg, −15.3 kg to 2.2 kg, respectively. Female athletes were −1.5 to 0.5 kg, −5.9 to 0.4 kg [18]. Raymond et al. [17] also compared the DXA of male college football players, and the correlation coefficients between the LOA and the FFM of the upper and lower extremities of the men’s athletes in Inbody770 were −0.43 to 3.23 kg (r = 0.82), 0.73 to 9.97 kg (r = 0.78) [17]. The results of Esco et al. [18] showed that the LOA of Inbody720 in upper and lower extremity FFM of female college athletes was −0.74 to 0.84 kg (r = 0.89) and −3.03 to 2.21 kg (r = 0.83), respectively [18]. Most existing commercial multi-limb bioimpedance analyzers are designed for use in a standing position and are equipped with stainless steel electrode plates to measure the resistance and reactance of the limbs and trunk at different frequencies. In this study, the resistance and reactance of a single section from the dorsum of the right palm to the dorsum of the right foot were measured in a supine position using electrodes. The resistance and reactance measurement environments required for the Sardinha equation compared in this study were also supine with adhesive electrodes. Although different from the BIA device (BIA 101 Anniversary AKERN/RJL Systems; Florence, Italy) used by Sardinha et al. [23], the InBody S-10 used in this study underwent standard resistance and reactance correction procedures. This ensures the accuracy of the measured resistance and reactance. Almost all of the above studies have expressed that the current commercial BIA multi-limb body composition analyzer has errors and limited correlation in the measurement results of bone mineral content of upper and lower extremities and FFM of LSTM for athletes of different sports. Therefore, it is necessary to establish the estimation equation of LSTM or FFM of arms and legs for athletes. But in fact, for the research of BIA measurement equation of LSTM or FFM of athletes’ arms or legs is very limited. Sardinha et al. [23] developed the estimation equation for limb LSTM for single-frequency BIA in Caucasian athletes. The results of the LSTM estimation equation in the VG of that study were that the LOA and correlation coefficient of the lower limb LSTM were −1.11 to 1.32 kg (r = 0.90) and −3.78 to 3.87 kg (r = 0.94), respectively. Using the resistance, reactance and anthropometric parameters of athletes in Taiwan as entered into the estimation equation of Sardinha et al. [23], the correlation coefficients between the estimated results of ArmsLSTM, LegsLSTM with DXA were r = 0.81 and 0.86, respectively. The LOAs of Bland-Altman plots were −2.70 to 2.14 kg and −6.96 to 2.32 kg, respectively. The estimation equation established by Sardinha et al. [23] is better than the existing commercial BIA device in the measurement of LSTM or FFM of Arms and Legs. Therefore, it is necessary to establish an athlete-specific LSTM measurement equation for arms and legs.

This study and Sardinha et al. [23] both used stepwise regression analysis and the same candidate estimated variables. The ArmsLSTM measurement equation of this study was selected after stepwise regression analysis. The measured variables were h2/R, Sex, Xc and h. The estimated variables of the LegsLSTM equation were h2/R, h, Sex, Weight, Age and Xc. Compared with Sardinha et al., the LegsLSTM equation in this study has more estimated variables for h, Age, and Xc. The BIA estimation equations ArmsLSTMBIA-Asian and LegsLSTMBIA-Asian obtained had LOA and correlation coefficients in the cross-validation group of −1.53 to 1.43 kg (r = 0.921), −2.68 to 2.90 kg (r = 0.957). Compared with the LSTM estimation equation developed by Sardinha et al., the LSTM estimation equation developed in the present study is not only suitable for Asian athletes, but also has better overall performance in legs estimation. In this study, the estimated variables selected in sequence in the application of stepwise regression analysis were shown. It was shown in the results that the addition of Xc has little effect on the coefficient of determination of the estimated equation. But between Xc and LegsLSTM or ArmsLSTM respectively reached a moderate negative correlation, and will have a certain impact on reducing SEE.

Changes in body composition of the whole body or limb region may provide additional information on exercise science. In particular, it can be used to formulate an effective training program for different sports and positions. Therefore, in the future research direction, it is necessary to measure the body composition of each limb, especially the measurement of and research results for LSTM, in addition to the measurement of athletes’ body composition. This prospective observational study applied supine bioimpedance measurements to validate the LSTM reported by Sardinha et al. [23] for extremities. Corrections for resistance and reactance were also performed before the experiment, and the study was replicated with reference to its experimental protocol.

Sex, sports, position, endurance sports, resistance sports or a mixture of the latter two will all affect the athlete’s body composition. Because Sex has been added into the estimated variable in the stepwise regression analysis in the newly constructed estimation equation in this study. Therefore, this study has included both men and women and used the same equation to estimate their LSTM. At present, there are only a few studies on the body composition estimation equation of athletes’ bioimpedance in a single sport [31]. In contrast, the scope of application of a single sport is also relatively limited. If the LSTM for athletes is added to the variable of their sport, or the sports are classified to construct and verify their LSTM estimation equations, it will definitely be more suitable for the athlete’s composition measurement of their corresponding sports. Perhaps this could also be a good research direction in the future.

In the application of stepwise regression analysis, the estimation variables of the estimation equations entered first by ArmsLSTM or LegsLSTM were all h2/R. Weight also achieves high correlation for ArmsLSTM or LegsLSTM. However, it can be observed from the correlation coefficient matrix, Weight and reactance are positively correlated with ArmLSTM, LegsLSTM and estimated variables, but Weight is still greater than reactance. This was also reflected in the selection order of LSTM estimation equations for estimated variables. In this study, if only the four parameters of age, height, weight, and sex were used as estimation variables, and ArmLSTM and LegLSTM were used as dependent variables, the R² and SEE of the estimation equation obtained through linear stepwise regression analysis were 0.790 and 1.020 kg, and 0.867 and 1.619 kg, respectively. When R and Xc were added to the estimation equation, the R² and SEE improved to 0.855 and 0.757 kg, and 0.916 and 1.431 kg, respectively. This demonstrates a significant improvement in the estimation accuracy of the equation. Additionally, h²/R has a higher estimation or explanatory ability for ArmLSTM or LegLSTM compared to anthropometric predictions.

Regarding the selection of estimation variables in this study, it is important to consider not only the commonly used variables in bioimpedance analysis but also their physiological significance, the correlation between the selected estimation variables and their response variables, ease of measurement, measurement accuracy, reproducibility, and collinearity.

Athletes have a unique body composition [32] compared to non-athletes due to the requirements of competitive sports. Therefore, there may be larger errors when the LSTM measurement equation of BIA from non-athletes [33] are applied to athletes using. Relative compared with BIA used to measure the quantity of body composition, bioelectrical impedance vector analysis (BIVA) can be used to identify the subject’s water and hydration status. Through the qualitative analysis of BIVA, it is possible to avoid make the relevant problem of BIA. Using BIVA can’t estimate the body composition, but can draw the tolerance ellipses for specific ethnic groups such as athletes to evaluate the vector position. Qualitative analysis of BIVA can be used for comparing the physical characteristics [34, 35].

The equations established in this study are specific to the equipment and populations used. The use of BIA to measure body composition has a certain relationship with the geometric shape of the human body. Therefore, there may be certain estimation errors in the measurement of different special athletes. Furthermore, we used whole body rather than segmental impedance measurements. Therefore, in theory, the use of whole-body bioimpedance measurement devices to estimate athletes’ LSTM may be inferior to that of segmental measurement devices. However, the results presented in this study are not worse than commercially available segmental bioimpedance measurement devices. It is also worth mentioning that it is a good choice to develop estimation equations for athletes of a single sport in the future. At the same time, it would be a better research direction if the differences of race can be considered. In addition, the study subjects were all elite athletes recruited in Taiwan whose data contributed to formulating the limbs LSTM estimation equations, which limits the extent to which study results can be generalized to other populations. Whether results of the present study are applicable to other races still needs to be verified in further studies. The goal of this study is to develop an LSTM estimation equation for Asian athletes using the bioimpedance analysis method. This will be compared with the LSTM estimation equation for European athletes using the same measurement method to elucidate the differences in the estimation equations between races. Validation and comparison of existing commercial bioimpedance devices against users’ body composition or LSTM estimation results is a crucial area of research, particularly for athletes. This study could lead to further research in this direction.

A key objective of this study is to demonstrate that athletes of different races require race-specific samples to develop accurate estimation equations. The bioimpedance analysis method offers more valuable body composition measurements compared to anthropometric methods. Although the LSTM estimation equation published in this study cannot be used in clinical applications due to significant estimation errors, it still provides a convenient method for monitoring the LMST of athletes. This method is safe, non-invasive, and convenient.

In the future, based on this study, measuring the resistance and reactance of each limb at different frequencies and incorporating more anthropometric predictions should bring the method closer to clinical application.

Conclusion

Single-frequency BIA estimation equations of LSTM for arms and legs of Asian athletes in Taiwan have been established and have demonstrated good performance, allowing them to quickly and accurately measure lean soft tissue mass of the arms and legs of Asian athletes. Nevertheless, BIA estimation equations of the limbs LSTM for Caucasian athletes should be carefully evaluated when applied to the measurement of the limb LSTM of Asian athletes. It is recommended that when Asian athletes measure the muscle mass of their limbs, they must use a specific and verified BIA estimation equation of limb LSTM, so that the measurement results can be actually used for reference value.

Supporting information

S1 File

(XLSX)

pone.0300911.s001.xlsx (21.7KB, xlsx)

Data Availability

All relevant data are contained in the paper and its Supporting information files.

Funding Statement

This work was supported by grants from the Tzu Hui Institute of Technology Research Program (THIT-110004) and was supported in part by the National Science and Technology Council, Republic of China, under Grants MOST 111-2622-E-005-001. The funders had no role in the design of the study; in the collection, analysis, or interpretation of the data; in writing the manuscript or in the decision to publish the results.

References

  • 1.Wilmore JH. Body composition in sport and exercise: Directions for future research. Med. Sci. Sports Exerc. 1983; 15: 21–31. [PubMed] [Google Scholar]
  • 2.Meyer NL, Sundgot-Borgen J, Lohman TG, Ackland TR, Arthur D Stewart AD, Maughan RJ, et al. Body composition for health and performance: A survey of body composition assessment practice carried out by the Ad Hoc Research working group on body composition, health and performance under the auspices of the IOC Medical commission. Br. J. Sports Med. 2013; 47: 1044–53. doi: 10.1136/bjsports-2013-092561 [DOI] [PubMed] [Google Scholar]
  • 3.Ackland TR, Lohman TG, Sundgot-Borgen J, Maughan RJ, Meyer NL, Stewart AD, et al. Current status of body composition assessment in sport: review and position statement on behalf of the ad hoc research working group on body composition health and performance, under the auspices of the I.O.C. Medical Commission. Sports Med. 2021; 42: 227–49. [DOI] [PubMed] [Google Scholar]
  • 4.Silva AM. Structural and functional body components in athletic and performance phenotypes. Eur. Clin. Nutr. 2019; 73: 215–224. [DOI] [PubMed] [Google Scholar]
  • 5.Prado CM, Heymsfield SB. Lean tissue imaging: A new era for nutritional assessment and intervention. J. Parenter Enteral Nutr. 2014; 38: 940–53. doi: 10.1177/0148607114550189 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Czeck MA, Raymond-Pope CJ, Stanfort PR, Carbuhn A, Bosch TA, Bach CW, et al. Total and regional body composition of NCAA Division collegiate female softball athletes. Int. J. Sports Med. 2019; 40: 645–9. [DOI] [PubMed] [Google Scholar]
  • 7.Chiarlitti NA, Delisle-Houde P, Reid RE, Kennedy C, Andersen RE. Importance of body composition in the national hockey league combine physiological assessments. J. Strength Cond. Res. 2018; 32: 31135–42. doi: 10.1519/JSC.0000000000002309 [DOI] [PubMed] [Google Scholar]
  • 8.Roelfs E, Bockin A, Bosch T, Oliver J, Bach CW, Carbuhn A, et al. Body composition of National Collegiate Athletic Association (NCAA) Division I Female soccer athletes through competitive seasons. Int. J. Sports Med. 2020; 41: 766–70. doi: 10.1055/a-1177-0716 [DOI] [PubMed] [Google Scholar]
  • 9.Raymond-Pope CJ, Solfest AL, Carbuhn A, Stanforth PR, Oliver J, Bach CW, et al. Total and regional body composition of NCAA Division I Collegiate basketball athletes. Int. J. Sports Med. 2020; 41: 242–47. doi: 10.1055/a-1073-7941 [DOI] [PubMed] [Google Scholar]
  • 10.Dengel DR, Keller KA, Stanforth PR, Oliver JM, Carbuhn A, Bosch TA. Body composition and bone mineral density of Division 1 collegiate track and field athletes, a consortium of college athlete research (C-CAR) study. J. Clin. Densitiom. 2020; 3: 303–13. doi: 10.1016/j.jocd.2019.07.008 [DOI] [PubMed] [Google Scholar]
  • 11.Bosch TA, Carbuhn AF, Stanforth PR, Oliver JM, Keller KA, Dengel DR. Body composition and bone mineral density of Division 1 Collegiate football players: A consortium of college Athlete Research Study. J. Strength Cond. Res. 2019; 33: 1339–46. doi: 10.1519/JSC.0000000000001888 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Prokop NW, Reid RE, Andersen RE. Seasonal changes in whole body and regional body composition profiles of elite collegiate ice-hockey players. J. Strength Cond. Res. 2016; 30: 684–92. doi: 10.1519/JSC.0000000000001133 [DOI] [PubMed] [Google Scholar]
  • 13.Silverstre R, Kreamer WJ, Wes C, Kraemer WJ. Body composition and physical performance during a National Collegiate Athletic Association Division I men’s soccer season. J. Strength Cond. Res. 2006; 20: 962–83. doi: 10.1519/R-18165.1 [DOI] [PubMed] [Google Scholar]
  • 14.Lukaski HC, Bolonchuk WW, Siders WA, Hall CB. Body composition assessment of athletes using bioelectrical impedance measurements. J. Sports Med. Phys. Fit. 1990; 30: 434–40. [PubMed] [Google Scholar]
  • 15.Segal KR. Use of bioelectrical impedance analysis measurements as an evaluation for participating in sports. Am. J. Clin. Nutr. 1996; 64(3): 469S–71S. doi: 10.1093/ajcn/64.3.469S [DOI] [PubMed] [Google Scholar]
  • 16.Brewer GJ, Blue MNM, Hirsch KR, Peterjohn AM, Smith-Ryan AE. Appendicular body composition analysis: validity of bioelectrical impedance compared with Dual-energy x-ray absorptiometry in division I college athletes. J. Strength Cond. Res. 2019; 33(11): 2029–25. [DOI] [PubMed] [Google Scholar]
  • 17.Raymond CG, Dengel DR, Bosch TA. Total and segment body composition examination in collegiate football players using multifrequency bioelectrical impedance analysis and dual x-ray absorptiometry. J. Strength Cond. Res. 2018; 32: 772–82. [DOI] [PubMed] [Google Scholar]
  • 18.Esco MR, Snarr RL, Leatherwood MD, Chamberlain NA, Redding ML, Flatt AA. Comparison of total and segmental body composition using DXA and multifrequency bioimpedance in collegiate female athletes. J. Strength Cond. Res. 2015; 29: 918–25. doi: 10.1519/JSC.0000000000000732 [DOI] [PubMed] [Google Scholar]
  • 19.Sedeaud A, Marc A, Schipman J, Schaal K, Danial M, Guillaume M, et al. Secular trend: Morphology and performance. J. Sports Sic. 2014; 32: 1146–54. doi: 10.1080/02640414.2014.889841 [DOI] [PubMed] [Google Scholar]
  • 20.Moon JR. Body composition in athletes and sports nutrition: An examination of the bioimpedance analysis technique. Eur. J. Clin. Nutr. 2013; 67: S54–9. doi: 10.1038/ejcn.2012.165 [DOI] [PubMed] [Google Scholar]
  • 21.Matias CN, Santo DA, Judice PB, Magalhães JP, Minderico CS, Fields DA, et al. Estimation of total body water and extracellular water with bioimpedance in athletes: A need for athlete-specific prediction models. Clin. Nutr. 2016; 35: 468–74. doi: 10.1016/j.clnu.2015.03.013 [DOI] [PubMed] [Google Scholar]
  • 22.Matias CN, Campa F, Santos DA, Lukaski H, Sardinha LB, Silva AM. Fat-free mass bioelectrical impedance analysis predictive equation for athletes using a compartment model. Int. J. Sports Med. 2021; 42: 27–32. [DOI] [PubMed] [Google Scholar]
  • 23.Sardinha LB, Correia IR, Magalhaes JP, Júdice PB, Silva AM, Megan H-R. Development and validation of BIA prediction equations of upper and lower limb lean soft tissue in athletes. Eur. J. Clin. Nutr. 2020; 74: 1646–52. doi: 10.1038/s41430-020-0666-8 [DOI] [PubMed] [Google Scholar]
  • 24.Deurenberg P, Deurenberg-Yap M, Schouten FJ. Validity of total and segmental impedance measurements for prediction of body composition across ethnic population groups. Eur. J. Clin. Nutr. 2002; 56: 214–20. doi: 10.1038/sj.ejcn.1601303 [DOI] [PubMed] [Google Scholar]
  • 25.Fornetti WC, Pivarnik JM, Foley JM, Fiechtner JJ. Reliability and validity of body composition measures in female athletes. J Appl Physiol, 1985; 87: 1114–22. [DOI] [PubMed] [Google Scholar]
  • 26.Graybeal AJ, Moore ML, Cruz MR, Tinsley GM. Body composition assessment in male and female bodybuilders: a 4-compartment model comparison of dual-energy X-ray absorptiometry and impedance-based devices. J Strength Cond Res. 2020; 34:1676–89. doi: 10.1519/JSC.0000000000002831 [DOI] [PubMed] [Google Scholar]
  • 27.Campa F, Gobbo LA, Stagi S, Cyrino LT, Toselli S, Marini E. Bioelectrical impedance analysis versus reference methods in assessment of body composition in athletes. European Journal of Applied Physiology. 2022; 122: 561–89. [DOI] [PubMed] [Google Scholar]
  • 28.Deurenberg P, Deurenberg-Yap M. Validity of body composition methods across ethnic population groups. Acta Diabetologica. 2003; 40;S246–S249. doi: 10.1007/s00592-003-0077-z [DOI] [PubMed] [Google Scholar]
  • 29.Surała O, Malczewska-Lenczowska J, Crewther BT. Contemporaneous and temporal interrelationships between menstrual fluctuations in sex hormones and DXA estimates of body composition in a premenopausal female: a case study. J Sports Med Phys Fitness, 2021; 61:1423–28. doi: 10.23736/S0022-4707.20.11757-2 [DOI] [PubMed] [Google Scholar]
  • 30.Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J. Appl. Physiol. (1985). 2000; 89: 465–71. doi: 10.1152/jappl.2000.89.2.465 [DOI] [PubMed] [Google Scholar]
  • 31.Pichard C, Kyle UG, Gremion G, Gerbase M, Slosman DO. Body composition by x-ray absorptiometry and bioelectrical impedance in female runners. Medicine & Science in sports & Exercise. 1997; 29: 1527–34. doi: 10.1097/00005768-199711000-00021 [DOI] [PubMed] [Google Scholar]
  • 32.Prior BM, Modlesky CM, Evans EM, Sloniger MA, Saunders MJ, Lewis RD. Muscularity and the density of the fat-free mass in athletes. J Appl Physiol. (1985). 2001; 90: 1523–31. doi: 10.1152/jappl.2001.90.4.1523 [DOI] [PubMed] [Google Scholar]
  • 33.Beaudra C, Bryyere O, Geerinck A, Hajaoui M, Scafoglieri A, Perkisas S. Equation model developed with bioelectrical impedance analysis tools to assess muscle mass: a systematic review. Clin Nutr. 2020; 35:47–62. [DOI] [PubMed] [Google Scholar]
  • 34.Campa F, Matias C, Gatterer H, Toselli S, Koury JC. Angela Andreoli. et al. Classic bioelectrical impedance vector reference values for assessing body composition in male and female athletes. Int J Environ Res Public Health. 2019; 16(24): 5066. doi: 10.3390/ijerph16245066 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Francesco C, Stefania T, Massimiliano M, Luis AG. Giuseppe C. Assessment of body composition in athletes: A narrative review of available methods with special reference to quantitative and qualitative bioimpedance analysis. Nutrients. 2021;12:1620. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Gianpiero Greco

12 Apr 2024

PONE-D-24-08399Estimation equation of limb lean soft tissue mass in Asian athletes using bioelectrical impedance analysisPLOS ONE

Dear Dr. Hsieh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 27 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Gianpiero Greco

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"This work was supported by grants from the Tzu Hui Institute of Technology Research Program (THIT-110004) and was supported in part by the National Science and Technology Council, Republic of China, under Grants MOST 111-2622-E-005-001."

We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"This work was supported by grants from the Tzu Hui Institute of Technology Research Program (THIT-110004) and was supported in part by the National Science and Technology Council, Republic of China, under Grants MOST 111-2622-E-005-001."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following financial disclosure:

"This work was supported by grants from the Tzu Hui Institute of Technology Research Program (THIT-110004) and was supported in part by the National Science and Technology Council, Republic of China, under Grants MOST 111-2622-E-005-001."    

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. Thank you for stating the following in the Competing Interests/Financial Disclosure * (delete as necessary) section:

"The authors have read the journal’s policy and have the following competing interests: Dr. Kuen-Chang Hsieh was employed by a commercial company, StarBIA Meditek Co. Ltd., during this study. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare. All other authors have no conflicts of interest to declare. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results."

We note that you received funding from a commercial source: "StarBIA Meditek Co. Ltd"

Please provide an amended Competing Interests Statement that explicitly states this commercial funder, along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products, etc.

Within this Competing Interests Statement, please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include your amended Competing Interests Statement within your cover letter. We will change the online submission form on your behalf.

Additional Editor Comments :

Dear Authors,

please reply point by point to the reviewers' comments.

Many thanks!

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Authors

the manuscript describe the validation of a new equation to predict limb lean soft tissue mass from BIA assessment in asian athletes.

This is my comment:

- in general the introduction appear too dispersive and the focus on the aim of the study is only in the end of the section. Much more references are used, some appear dated and others not relevant to the sentence (i.e. ref. 5).

- pag 2 line 66: please check "of muscle and muscle volume (MV),"

- is necessary a reference at pag. 4, line 102 "There are certain differences in the physiological quality of different races. Therefore, it is necessary to establish and verify the measurement equations of LSTM and BIA for Asian athletes."

- There is the use of "racial" terminology. Probably "ethnicity" is more appropriate. In addition, there are no information about the different socio-cultural habits in different populations instead the ethnicity-anthropological approach used in this manuscript.

- Why the authors choose to perform the assessments at 1:00 p.m? Before or after the lunch?

- no reference were reported for reliability of the instrumentation used in the manuscript.

- table 2 and table 3 is not clear. Please ensure the presentation.

- The authors performed a comparison of Sardinha equation. However, the Sardinha study was performed with a different BIA device. Please stated this aspect in discussion section and justify this choice.

- fig. 2 and 3 not reported any statistical results. Please add some additional informations.

- Why the authore not perfomed the ROC analysis as in 10.1186/s12967-023-04795-z

- please add some comment about the results described in fig. 3 b. and 3 d. Please clarify.

Reviewer #2: Abstract and elsewhere in the manuscript. The authors must make it clear that generated prediction equations are only applicable to measurements obtained at the locations used by the InBody device. These are unusual and not the commonly used wrist-ankle locations or the sole and palm as used in conventional stand-on devices.

Line 70 Strictly, BIA is considered a two-compartment model; a conductive compartment (FFM)and a non-conductive compartment (fat). It is a predictive or estimating method. It does NOT measure BMC although BIA manufacturers frequently provide a doubly indirect estimate. Please correct to describe BIA accurately as a 2C system.

Line 71 "non-penetrating" I believe that you mean non-invasive.

Line 86 onward. Again please avoid suggesting that BIA MEASURES body composition, e.g. line 9. It PREDICTS or ESTIMATES BC.

Line 146 Please make it clear whether you are simply making whole body impedance measurements or that the device measures segments.

Line 148. Why was this analyser used when the authors had available an alternative analyser (line 137). Why was the opportunity not taken to compare predictions from the two commercial analysers. In addition to testing their own equation? This would have added to the study.

Line 171. Were the ROI those provided by the software or adjusted/optimised by the DXA operator?

Lines 210-216. Please highlight some key observations from these data, e.g., a male female difference, apparent proportional effect in the LOA plots. At present, essentially fig titles are simply presented.

Line 217. Please state what was the basis for variable selection. Those chosen are typical for this type of study but their inclusion should be justified.

Line 218. Sex not gender.

Line 240 What is this reproducibility measure? How was it calculated? Does it have units?

Line 251. This picks up my first point. That empirically-derived prediction equations are population/device specific. Also highlights my point about why you did not test your Tanita predictions.

Line 284.and elsewhere. You quote absolute LOA, e.g., approximately +/-2.8 kg for leg LSTM. Since leg LSTM is around 19 kg, these LOA equate to about +/-15%. In practice the question is whether this level of inaccuracy is clinically acceptable? Would an athlete or coaches be happy with an estimate of LSTM with +/-15% LOA error. This point must be addressed. Your equation may perform better than the Sardinha equation but it may still not be sufficiently accurate for practical use.

Line 312. It is often found that inclusion of BIA in algorithms only improves prediction marginally compared to simple anthropometric predictions. Was this actually tested? If not why not?

Line 327 Include in limitations that the equation is specific to this device and population.

Line 347

What do you mean here by "proprietary"? Are you suggesting manufacturer's predictions?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Aug 28;19(8):e0300911. doi: 10.1371/journal.pone.0300911.r002

Author response to Decision Letter 0


1 Jun 2024

Reviewer #1: Dear Authors

the manuscript describe the validation of a new equation to predict limb lean soft tissue mass from BIA assessment in asian athletes.

This is my comment:

- in general the introduction appear too dispersive and the focus on the aim of the study is only in the end of the section. Much more references are used, some appear dated and others not relevant to the sentence (i.e. ref. 5).

Response:

Thank you for your suggestion. We have revised this and deleted the narrative on lines 58-63 in the manuscript to make it more narrative, rigorous and easier to read, as shown in the revised manuscript. The above modifications streamline redundant words and also de-cite outdated documents.

- pag 2 line 66: please check "of muscle and muscle volume (MV),"

Response:

Thank you for the reminder, we have revised this statement to "Although CT and MRI provide information on muscle cross-sectional areas (CSA) and muscle volume (MV)," as shown in the revised manuscript.

- is necessary a reference at pag. 4, line 102 "There are certain differences in the physiological quality of different races. Therefore, it is necessary to establish and verify the measurement equations of LSTM and BIA for Asian athletes."

Response:

Thank you for your suggestion, we have added the appropriate reference [30], and revised its description to " More cross-ethnic population studies on body composition are warranted. These studies should be meticulously conducted, employing suitable methodologies and standardization, to ensure the value of the gathered information [30].

30. Deurenberg P, Deurenberg-Yap M. Validity of body composition methods across ethnic population groups. Acta Diabetologica. 2003; 40;S246-S249.

- There is the use of "racial" terminology. Probably "ethnicity" is more appropriate. In addition, there are no information about the different socio-cultural habits in different populations instead the ethnicity-anthropological approach used in this manuscript.

Response:

Thank you for your suggestion, we have revised "racial" to "ethnicity".

- Why the authors choose to perform the assessments at 1:00 p.m? Before or after the lunch?

Response:

Thank you for your reminder, 1:00 pm is the benchmark point for a unified experiment, “and there is no lunch to maintain a fasting state before measurement." This description has been added to the Methods section, line 126-127.

- no reference were reported for reliability of the instrumentation used in the manuscript.

Response:

Thank you for your suggestions and reminders, " The InBody S-10 is a Class II medical device approved by the FDA (Regulation Number: 870.2770).", this description has been added to the Methods section, line 144-145.

- table 2 and table 3 is not clear. Please ensure the presentation.

Response:

Thank you for your reminder and suggestions. " The estimated variables selected in the stepwise regression analysis method, along with the corresponding regression coefficients, intercept, SEE, determination coefficient, variance inflation factor, and standardized coefficient of the estimation equation, are shown in Tables 2 and 3. In the stepwise regression analysis method, ArmLSTM was used as the response variable. : "," Table 2 and Table 3 have shown the choosing estimation variables and their orders when evaluating ArmsLSTM and LegsLSTM." This description has been added to the Results section, line 2223-226.., line 238-239 respectively.

- The authors performed a comparison of Sardinha equation. However, the Sardinha study was performed with a different BIA device. Please stated this aspect in discussion section and justify this choice.

Response:

Thank you for your suggestions and reminders. " The resistance and reactance measurement environments required for the Sardinha equation compared in this study were also supine with adhesive electrodes. Although different from the BIA device (BIA 101 Anniversary AKERN/RJL Systems; Florence, Italy) used by Sardinha et al. [23], the InBody S-10 used in this study underwent standard resistance and reactance correction procedures. This ensures the accuracy of the measured resistance and reactance.” This narrative has been added to the revised manuscript in the discussion section, line 288-293.

- fig. 2 and 3 not reported any statistical results. Please add some additional informations.

Response:

Thank you for your reminder and suggestions. ” Figures 2a and 2c are scatter plots of ArmsLSTM and LegsLSTM estimates compared to DXA results using the Sardinha equation. The regression line (thin solid line) shows a weak fit with the equivalence line (dashed line), indicating that the accuracy of the Sardinha equation for estimating ArmsLSTM and LegsLSTM in Asian athletes is limited. The Bland-Altman plots in Figures 2b and 2d show the limits of agreement (LOA) for ArmsLSTM and LegsLSTM estimates using the Sardinha equation in Asian athletes. The trend line (dashed line) in the plots indicates a significant proportional bias between the two measurement methods.

Figures 3a and 3c show scatter plots of ArmsLSTM and LegsLSTM estimates compared to DXA results for the validation group. The regression line (thin solid line) closely aligns with the equivalence line (dashed line). The Bland-Altman plots in Figures 3b and 3d represent the ArmsLSTM and LegsLSTM estimation equations established by the model group. This indicates no proportional error in the validation group's estimated results. The limits of agreement (LOA) in Figures 3b and 3d are significantly narrower than those in Figures 2b and 2d." This description is added to the Result section, line 216-222, line 244-249.

- Why the authore not perfomed the ROC analysis as in 10.1186/s12967-023-04795-z

Response:

Thank you for your suggestions and reminders. The main purpose of this study is to confirm the applicability of the established LMST for athletes of different races, and also to establish equations suitable for Asian athletes for estimating LSTM of upper and lower limbs. In addition, the models and verification groups are used for verification. Use statistical techniques such as stepwise regression analysis, Paired-t test, Lin’s concordance correlation coefficient, Bland-Altman Plots, intraclass correlation coefficient and other statistical techniques to conduct data analysis. These indicators and methods are the same as the statistical analysis in Sardinha equation [23], which is more conducive to comparison between this study and Sardinha equation [23]. The above indicators have included most of the statistical analysis tools and result interpretation required for this study.

- please add some comment about the results described in fig. 3 b. and 3 d. Please clarify.

Response:

Thank you for your reminder. As suggested above, we have added the supplementary description to the Results Section, Line 244-249.

Reviewer #2:

Abstract and elsewhere in the manuscript. The authors must make it clear that generated prediction equations are only applicable to measurements obtained at the locations used by the InBody device. These are unusual and not the commonly used wrist-ankle locations or the sole and palm as used in conventional stand-on devices.

Response:

Thank you for your suggestions and reminders. We have strengthened the description of the measurement methods and limitations in the Abstract, Methods, and Discussion of the manuscript. The description " Using the InBody S-10, resistance and reactance were measured at 50 kHz from the right palm to the right sole while the participant was in the supine position. " was added to the Abstract. " Resistance and reactance were measured from the dorsum of the right palm to the dorsum of the right foot using a bioimpedance analyzer, the S-10 (InBody Co., Ltd., Seoul, South Korea), operating at a frequency of 50 kHz while the participant was in a supine position. " was added to the Methods. " Most existing commercial multi-limb bioimpedance analyzers are designed for use in a standing position and are equipped with stainless steel electrode plates to measure the resistance and reactance of the limbs and trunk at different frequencies. In this study, the resistance and reactance of a single section from the dorsum of the right palm to the dorsum of the right foot were measured in a supine position using electrodes." was added to the Discussion section.

Line 70 Strictly, BIA is considered a two-compartment model; a conductive compartment (FFM)and a non-conductive compartment (fat). It is a predictive or estimating method. It does NOT measure BMC although BIA manufacturers frequently provide a doubly indirect estimate. Please correct to describe BIA accurately as a 2C system.

Response:

Thank you for your reminder and suggestions. As stated here, the three-compartment model has been revised to the two-compartment model.

Line 71 "non-penetrating" I believe that you mean non-invasive.

Response:

Thank you for your suggestions and reminders, we have revised it to non-invasive.

Line 86 onward. Again please avoid suggesting that BIA MEASURES body composition, e.g. line 9. It PREDICTS or ESTIMATES BC.

Response:

Thank you for your suggestions and reminders. In addition to revising this to “estimate”, we have also revised other similar issues in the manuscript.

Line 146 Please make it clear whether you are simply making whole body impedance measurements or that the device measures segments.

Response:

Thank you for your reminders and suggestions. We have revised or supplemented the Introduction section and Abstract section respectively to make readers more intuitively understand that this study was to establish the impedance measurement mode of the whole body.

Line 148. Why was this analyser used when the authors had available an alternative analyser (line 137). Why was the opportunity not taken to compare predictions from the two commercial analysers. In addition to testing their own equation? This would have added to the study.

Response:

Thank you for your suggestions and reminders. " The goal of this study is to develop an LSTM estimation equation for Asian athletes using the bioimpedance analysis method. This will be compared with the LSTM estimation equation for European athletes using the same measurement method to elucidate the differences in the estimation equations between races. Validation and comparison of existing commercial bioimpedance devices against users' body composition or LSTM estimation results is a crucial area of research, particularly for athletes. This study could lead to further research in this direction. " The above description has been added to the Discussion section, line 384-390.

Line 171. Were the ROI those provided by the software or adjusted/optimised by the DXA operator?

Response:

Thank you for your suggestions and reminders. “The regions of interest (ROI) for the whole body, trunk, legs, arms, android, and gynoid were automatically determined by the software.” This statement has been added to the Methods section, Line 169-170 in the revised manuscript.

Lines 210-216. Please highlight some key observations from these data, e.g., a male female difference, apparent proportional effect in the LOA plots. At present, essentially fig titles are simply presented.

Response:

Thank you for your suggestion." This study used data measured from Asian athletes and applied the equation of Sardinha et al. For the upper limbs, the LSTM of female athletes was generally overestimated, while the LSTM of male athletes was slightly underestimated. For the lower limbs, the LSTM of male athletes was significantly underestimated. These results showed clear proportional effects, with greater underestimation as the LSTM of the upper and lower limbs increased. Therefore, the applicability of the LSTM estimation equation established for European athletes to Asian athletes must be carefully evaluated." This description has been added to the Discussion section, line 267-273.

Line 217. Please state what was the basis for variable selection. Those chosen are typical for this type of study but their inclusion should be justified.

Response:

Thank you for your reminder and suggestions. " Regarding the selection of estimation variables in this study, it is important to consider not only the commonly used variables in bioimpedance analysis but also their physiological significance, the correlation between the selected estimation variables and their response variables, ease of measurement, measurement accuracy, reproducibility, and collinearity.” This description was added to the Discussion section, line 358-361 in the revised manuscript.

Line 218. Sex not gender.

Response:

Thank you for your reminder and suggestions. In addition to correcting this, we have also corrected other similar problems in the manuscript, as shown in the revised manuscript.

Line 240 What is this reproducibility measure? How was it calculated? Does it have units?

Response:

Thank you for your suggestions and reminders. " Intraclass correlation coefficient (ICC) analysis was conducted using two repeated measurements to assess the reproducibility of estimating ArmsLSTM and LegsLSTM in this study. The measurement unit was kilograms (kg)." This description has been added to the revised manuscript , Statistical analysis section, Line 196-198.

Line 251. This picks up my first point. That empirically-derived prediction equations are population/device specific. Also highlights my point about why you did not test your Tanita predictions.

Response:

Thank you again for your suggestions and reminders. Regarding your suggestion "to explore the verification of LSTM measured by commercial body composition analyzers in athletes", I also think it is a very important research direction. The Tanita BC-418MA used to measure body weight in this study was discontinued approximately ten years ago. The Inbody S-10 used in this study to measure resistance and reactance is believed to have more research value if it is used to verify the estimation results of athletes' body composition against commercial BIA devices such as the commonly used and standing Inbody 770. This is also our future research direction.

Line 284.and elsewhere. You quote absolute LOA, e.g., approximately +/-2.8 kg for leg LSTM. Since leg LSTM is around 19 kg, these LOA equate to about +/-15%. In practice the question is whether this level of inaccuracy is clinically acceptable? Would an athlete or coaches be happy with an estimate of LSTM with +/-15% LOA error. This point must be addressed. Your equation may perform better than the Sardinha equation but it may still not be sufficiently accurate for practical use.

Response:

Thank you for your reminder and suggestions. " A key objective of this study is to demonstrate that athletes of different races require race-specific samples to develop accurate estimation equations. The bioimpedance analysis method offers more valuable body composition measurements compared to anthropometric methods. Although the LSTM estimation equation published in this study cannot be used in clinical applications due to significant estimation errors, it still provides a convenient method for monitoring the LMST of athletes. This method is safe, non-invasive, and convenient.

In the future, based on this study, measuring the resistance and reactance of each limb at different frequencies and incorporating more anthropometric predictions should bring the method closer to clinical application." The above narrative has been added to Discussion section, Line 391-399, as shown in revised manuscript.

Line 312. It is often found that inclusion of BIA in algorithms only improves prediction marginally compared to simple anthropometric predictions. Was this actually tested? If not why not?

Response:

Thank you for your suggestion. " In this study, if only the four parameters of age, height, weight, and sex were used as estimation variables, and ArmsLSTM and LegsLSTM were used as dependent variables, the R² and SEE of the estimation equation obtained through linear stepwise regression analysis were 0.790 and 1.020 kg, and 0.867 and 1.619 kg, respectively. When R and Xc were added to the estimation equation, the R² and SEE improved to 0.855 and 0.757 kg, and

Attachment

Submitted filename: Plos One _ Reviese _20240527g.docx

pone.0300911.s002.docx (33.8KB, docx)

Decision Letter 1

Gianpiero Greco

26 Jun 2024

Estimation equation of limb lean soft tissue mass in Asian athletes using bioelectrical impedance analysis

PONE-D-24-08399R1

Dear Dr. Hsieh,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Gianpiero Greco

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: The authors have satisfactorily addressed the issues raised in my original review.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Acceptance letter

Gianpiero Greco

17 Jul 2024

PONE-D-24-08399R1

PLOS ONE

Dear Dr. Hsieh,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Gianpiero Greco

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (XLSX)

    pone.0300911.s001.xlsx (21.7KB, xlsx)
    Attachment

    Submitted filename: Plos One _ Reviese _20240527g.docx

    pone.0300911.s002.docx (33.8KB, docx)

    Data Availability Statement

    All relevant data are contained in the paper and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES